company background image
CPH

Creso Pharma ASX:CPH Stock Report

Last Price

AU$0.02

Market Cap

AU$41.1m

7D

-9.1%

1Y

-76.5%

Updated

01 Feb, 2023

Data

Company Financials

CPH Stock Overview

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific.

CPH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

New

Notes are coming soon

Creso Pharma Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Creso Pharma
Historical stock prices
Current Share PriceAU$0.02
52 Week HighAU$0.099
52 Week LowAU$0.018
Beta2.69
1 Month Change0%
3 Month Change-31.03%
1 Year Change-76.47%
3 Year Change-86.67%
5 Year Change-97.81%
Change since IPO-92.31%

Recent News & Updates

Recent updates

Shareholder Returns

CPHAU PharmaceuticalsAU Market
7D-9.1%-4.6%-0.3%
1Y-76.5%-30.2%2.4%

Return vs Industry: CPH underperformed the Australian Pharmaceuticals industry which returned -30.2% over the past year.

Return vs Market: CPH underperformed the Australian Market which returned 2.4% over the past year.

Price Volatility

Is CPH's price volatile compared to industry and market?
CPH volatility
CPH Average Weekly Movement14.7%
Pharmaceuticals Industry Average Movement9.6%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.6%
10% least volatile stocks in AU Market3.4%

Stable Share Price: CPH is more volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: CPH's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2015n/aWill Layhttps://www.cresopharma.com

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils.

Creso Pharma Limited Fundamentals Summary

How do Creso Pharma's earnings and revenue compare to its market cap?
CPH fundamental statistics
Market CapAU$41.14m
Earnings (TTM)-AU$18.15m
Revenue (TTM)AU$7.53m

5.2x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CPH income statement (TTM)
RevenueAU$7.53m
Cost of RevenueAU$6.10m
Gross ProfitAU$1.43m
Other ExpensesAU$19.58m
Earnings-AU$18.15m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0093
Gross Margin18.95%
Net Profit Margin-241.13%
Debt/Equity Ratio0%

How did CPH perform over the long term?

See historical performance and comparison